Half-year report · HY
8095.TEDINET S100YQAP
Period2025-12-01 → 2026-05-31
Filed2026-07-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥34.6bn | 2025-12-01 → 2026-05-31 | Cons. | Net sales |
| Revenue | ¥62.7bn | 2024-12-01 → 2025-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥30.1bn | 2024-12-01 → 2025-05-31 | Cons. | Net sales |
| Operating income | ¥2.3bn | 2025-12-01 → 2026-05-31 | Cons. | Operating income |
| Operating income | ¥2.2bn | 2024-12-01 → 2025-05-31 | Cons. | Operating income |
| Ordinary income | ¥2.1bn | 2025-12-01 → 2026-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.9bn | 2024-12-01 → 2025-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.1bn | 2024-12-01 → 2025-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.1bn | 2025-12-01 → 2026-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.0bn | 2024-12-01 → 2025-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.4bn | 2025-12-01 → 2026-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.2bn | 2024-12-01 → 2025-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2024-12-01 → 2025-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.4bn | 2025-12-01 → 2026-05-31 | Cons. | Profit loss |
| Net income | ¥1.3bn | 2024-12-01 → 2025-05-31 | Cons. | Profit loss |
| Total assets | ¥74.9bn | at 2026-05-31 | Cons. | Assets |
| Total assets | ¥75.9bn | at 2025-11-30 | Cons. | Assets |
| Total assets | ¥65.5bn | at 2025-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥46.1bn | at 2026-05-31 | Cons. | Liabilities |
| Total liabilities | ¥48.5bn | at 2025-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥28.8bn | at 2026-05-31 | Cons. | Net assets |
| Net assets / equity | ¥27.4bn | at 2025-11-30 | Cons. | Net assets |
| Net assets / equity | ¥26.0bn | at 2025-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.6bn | at 2026-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.2bn | at 2025-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.6bn | at 2026-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.1bn | at 2025-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.2bn | at 2025-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.0bn | at 2024-11-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.6bn | 2025-12-01 → 2026-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.4bn | 2024-12-01 → 2025-11-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.5bn | 2025-12-01 → 2026-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.6bn | 2024-12-01 → 2025-11-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.6bn | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.6bn | 2025-12-01 → 2026-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥6.2bn | 2024-12-01 → 2025-11-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥775m | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥35.1 | 2025-12-01 → 2026-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥54.36 | 2024-12-01 → 2025-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.97 | 2024-12-01 → 2025-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 38.0% | at 2026-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.7% | at 2025-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.5% | at 2025-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-12-01 → 2026-05-31 | ¥38m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-12-01 → 2026-05-31 | ¥35m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-12-01 → 2026-05-31 | −¥128m |
| Reconciling Itemsreconciling | revenue | 2025-12-01 → 2026-05-31 | −¥648m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-12-01 → 2026-05-31 | −¥648m |
| Reconciling Itemsreconciling | segment profit | 2025-12-01 → 2026-05-31 | ¥68m |
| Fine Chemicalsreportable segment | revenue | 2025-12-01 → 2026-05-31 | ¥11.4bn |
| Fine Chemicalsreportable segment | revenue external | 2025-12-01 → 2026-05-31 | ¥10.9bn |
| Fine Chemicalsreportable segment | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥434m |
| Fine Chemicalsreportable segment | segment profit | 2025-12-01 → 2026-05-31 | ¥729m |
| Health And Beauty Care Foodreportable segment | revenue | 2025-12-01 → 2026-05-31 | ¥11.4bn |
| Health And Beauty Care Foodreportable segment | revenue external | 2025-12-01 → 2026-05-31 | ¥11.4bn |
| Health And Beauty Care Foodreportable segment | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥37m |
| Health And Beauty Care Foodreportable segment | segment profit | 2025-12-01 → 2026-05-31 | ¥360m |
| Industrial Chemicalsreportable segment | revenue | 2025-12-01 → 2026-05-31 | ¥6.0bn |
| Industrial Chemicalsreportable segment | revenue external | 2025-12-01 → 2026-05-31 | ¥6.0bn |
| Industrial Chemicalsreportable segment | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥1m |
| Industrial Chemicalsreportable segment | segment profit | 2025-12-01 → 2026-05-31 | ¥606m |
| Medicalreportable segment | revenue | 2025-12-01 → 2026-05-31 | ¥6.4bn |
| Medicalreportable segment | revenue external | 2025-12-01 → 2026-05-31 | ¥6.3bn |
| Medicalreportable segment | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥172m |
| Medicalreportable segment | segment profit | 2025-12-01 → 2026-05-31 | ¥658m |
| —segment total | revenue | 2025-12-01 → 2026-05-31 | ¥35.2bn |
| —segment total | revenue external | 2025-12-01 → 2026-05-31 | ¥34.5bn |
| —segment total | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥645m |
| —segment total | segment profit | 2025-12-01 → 2026-05-31 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-12-01 → 2026-05-31 | ¥35.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-12-01 → 2026-05-31 | ¥34.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-12-01 → 2026-05-31 | ¥648m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-12-01 → 2026-05-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-12-01 → 2025-05-31 | ¥25m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-12-01 → 2025-05-31 | ¥17m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥7m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-12-01 → 2025-05-31 | −¥202m |
| Reconciling Itemsreconciling | revenue | 2024-12-01 → 2025-05-31 | −¥529m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-12-01 → 2025-05-31 | −¥529m |
| Reconciling Itemsreconciling | segment profit | 2024-12-01 → 2025-05-31 | ¥139m |
| Fine Chemicalsreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥11.9bn |
| Fine Chemicalsreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥11.6bn |
| Fine Chemicalsreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥319m |
| Fine Chemicalsreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥871m |
| Health And Beauty Care Foodreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥8.1bn |
| Health And Beauty Care Foodreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥8.0bn |
| Health And Beauty Care Foodreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥48m |
| Health And Beauty Care Foodreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥544m |
| Industrial Chemicalsreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥4.5bn |
| Industrial Chemicalsreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥4.5bn |
| Industrial Chemicalsreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥1m |
| Industrial Chemicalsreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥190m |
| Medicalreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥6.2bn |
| Medicalreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥6.0bn |
| Medicalreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥152m |
| Medicalreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥679m |
| —segment total | revenue | 2024-12-01 → 2025-05-31 | ¥30.6bn |
| —segment total | revenue external | 2024-12-01 → 2025-05-31 | ¥30.1bn |
| —segment total | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥521m |
| —segment total | segment profit | 2024-12-01 → 2025-05-31 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-12-01 → 2025-05-31 | ¥30.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-12-01 → 2025-05-31 | ¥30.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥529m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-12-01 → 2025-05-31 | ¥2.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 597
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash and cash equivalents | InterimInstant | 8640000000 | JPY |
| Packing and transportation expenses sga | Prior1InterimDuration | 877000000 | JPY |
| Packing and transportation expenses sga | InterimDuration | 951000000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1InterimDuration | -0 | JPY |
| Provision of allowance for doubtful accounts sga | InterimDuration | 3000000 | JPY |
| Compensations salaries and allowances sga | Prior1InterimDuration | 2648000000 | JPY |
| Compensations salaries and allowances sga | InterimDuration | 3176000000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 89000000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 92000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02585-000FineChemicalsReportableSegmentMember | 11558000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02585-000HealthAndBeautyCareFoodReportableSegmentMember | 8017000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02585-000MedicalReportableSegmentMember | 6009000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02585-000IndustrialChemicalsReportableSegmentMember | 4499000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReportableSegmentsMember | 30085000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 17000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 30102000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1InterimDuration | 30102000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02585-000FineChemicalsReportableSegmentMember | 319000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02585-000HealthAndBeautyCareFoodReportableSegmentMember | 48000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02585-000MedicalReportableSegmentMember | 152000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02585-000IndustrialChemicalsReportableSegmentMember | 1000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_ReportableSegmentsMember | 521000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 7000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 529000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | -529000000 | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02585-000FineChemicalsReportableSegmentMember | 11878000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02585-000HealthAndBeautyCareFoodReportableSegmentMember | 8066000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02585-000MedicalReportableSegmentMember | 6162000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02585-000IndustrialChemicalsReportableSegmentMember | 4501000000 | JPY |
| Net sales | Prior1InterimDuration_ReportableSegmentsMember | 30607000000 | JPY |
| Net sales | Prior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 25000000 | JPY |
| Net sales | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 30632000000 | JPY |
| Net sales | Prior1InterimDuration_ReconcilingItemsMember | -529000000 | JPY |
| Net sales | Prior1InterimDuration | 30102000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E02585-000FineChemicalsReportableSegmentMember | 871000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E02585-000HealthAndBeautyCareFoodReportableSegmentMember | 544000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E02585-000MedicalReportableSegmentMember | 679000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E02585-000IndustrialChemicalsReportableSegmentMember | 190000000 | JPY |
| Operating income | Prior1InterimDuration_ReportableSegmentsMember | 2286000000 | JPY |
| Operating income | Prior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -202000000 | JPY |
| Operating income | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 2083000000 | JPY |
| Operating income | Prior1InterimDuration_ReconcilingItemsMember | 139000000 | JPY |
| Operating income | Prior1InterimDuration | 2222000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E02585-000FineChemicalsReportableSegmentMember | 10930000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E02585-000HealthAndBeautyCareFoodReportableSegmentMember | 11359000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E02585-000MedicalReportableSegmentMember | 6250000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E02585-000IndustrialChemicalsReportableSegmentMember | 5989000000 | JPY |
| Revenues from external customers | InterimDuration_ReportableSegmentsMember | 34531000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |